MKC
33
-2
VLO
40
5
IR
74
-5
DOV
72
-4
HAS
42
-6
BRK.B
40
-2
HBAN
40
-5
MS
62
-2
AVY
71
-4
COST
69
2
NUE
34
-5
USB
42
-4
NOV
58
10
ORLY
58
-3
FMC
29
-2
ROK
50
6
CI
50
-3
DHI
57
-4
RF
45
-6
V
62
-4
MKC
33
-2
VLO
40
5
IR
74
-5
DOV
72
-4
HAS
42
-6
BRK.B
40
-2
HBAN
40
-5
MS
62
-2
AVY
71
-4
COST
69
2
NUE
34
-5
USB
42
-4
NOV
58
10
ORLY
58
-3
FMC
29
-2
ROK
50
6
CI
50
-3
DHI
57
-4
RF
45
-6
V
62
-4
Financhill
Back

Brookfield Asset Management Vs. Xtacy Therapeutics Industry Stock Comparison

Buy
52

BAM.TO
Brookfield Asset Management

Last Price:
52.05
Seasonality Move:
11.39%
Sell
32

XTCY.CX
Xtacy Therapeutics

Last Price:
0.03
Seasonality Move:
14.2%
Buy
52
Brookfield Asset Management (BAM.TO) is a Buy

Is Brookfield Asset Management a Buy, Sell or Hold?

  • The current Brookfield Asset Management [BAM.TO] share price is $52.38. The Score for BAM.TO is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • BAM.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Xtacy Therapeutics (XTCY.CX) is a Sell

Is Xtacy Therapeutics a Buy, Sell or Hold?

  • The current Xtacy Therapeutics [XTCY.CX] share price is $0.03. The Score for XTCY.CX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • XTCY.CX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BAM.TO Stock Price Chart

What is Brookfield Asset Management's stock price today?

  • The Brookfield Asset Management share price today is $52.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BAM.TO is experiencing buying pressure, which is a positive indicator for future bullish movement.

XTCY.CX Stock Price Chart

What is Xtacy Therapeutics's stock price today?

  • The Xtacy Therapeutics share price today is $0.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XTCY.CX is experiencing selling pressure, which indicates risk of future bearish movement.

BAM.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.5 Sell
Relative Strength Index (14 RSI): 45.51 Sell
Chaikin Money Flow: 797938 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.96 - 54.18) Sell
Bollinger Bands (100): (53 - 56.06) Sell

XTCY.CX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 42.19 Sell
Chaikin Money Flow: -20000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.03 - 0.05) Sell
Bollinger Bands (100): (0.04 - 0.06) Sell

BAM.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.19 Buy
20-day SMA: 52.66 Sell
50-day SMA: 53.48 Sell
200-day SMA: 51.08 Buy
8-day EMA: 52.27 Buy
20-day EMA: 52.69 Sell
50-day EMA: 53.42 Sell
200-day EMA: 51.46 Buy

XTCY.CX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.04 Sell
20-day SMA: 0.04 Sell
50-day SMA: 0.04 Sell
200-day SMA: 0.05 Sell
8-day EMA: 0.04 Sell
20-day EMA: 0.04 Sell
50-day EMA: 0.04 Sell
200-day EMA: 0.05 Sell

Brookfield Asset Management Earnings Growth & BAM.TO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.07 per share, an increase this year of $0.14 per share, and an increase next year of $0.37 per share.

Xtacy Therapeutics Earnings Growth & XTCY.CX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Brookfield Asset Management Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Xtacy Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):